Furthermore, Hurst et al. (2022) reported a notable correlation between the urinary microbiome and increased prostate cancer risk, along with traditional indicators such as prostate-specific antigen (PSA) levels, Gleason scores, and clinical stages [26]. This evidence concerns the gene KLK3 and prostate cancer.